HIV Citation List: October 24 - November 6, 2014
PubMed citations
1. Dilazep Synergistically Reactivates Latent HIV-1 in Latently Infected Cells. Zeng, H., S. Liu, P. Wang, X. Qu, H. Ji, X. Wang, X. Zhu, Z. Song, X. Yang, Z. Ma, and H. Zhu. Molecular Biology Reports, 2014. 41(11): p. 7697-7704. PMID[25091947].
[PubMed]. HIV_1024-110614.
2. Discovery of Small Molecular Inhibitors Targeting HIV-1 gp120-CD4 Interaction Derived from BMS-378806. Liu, T., B. Huang, P. Zhan, E. De Clercq, and X. Liu. European Journal of Medicinal Chemistry, 2014. 86: p. 481-490. PMID[25203778].
[PubMed]. HIV_1024-110614.
3. Phenyl-1-pyridin-2yl-ethanone-based Iron Chelators Increase IkappaB-Alpha Expression, Modulate CDK2 and CDK9 Activities, and Inhibit HIV-1 Transcription. Kumari, N., S. Iordanskiy, D. Kovalskyy, D. Breuer, X. Niu, X. Lin, M. Xu, K. Gavrilenko, F. Kashanchi, S. Dhawan, and S. Nekhai. Antimicrobial Agents and Chemotherapy, 2014. 58(11): p. 6558-6571. PMID[25155598].
[PubMed]. HIV_1024-110614.
4. Disulfide Reshuffling Triggers the Release of a Thiol-free anti-HIV Agent to Make Up Fast-acting, Potent Macromolecular Prodrugs. Kock, A., K. Zuwala, A.A. Smith, P. Ruiz-Sanchis, B.M. Wohl, M. Tolstrup, and A.N. Zelikin. Chemical Communications, 2014. 50(93): p. 14498-14500. PMID[25285337].
[PubMed]. HIV_1024-110614.
5. A Cyclic GB Virus C Derived Peptide with anti-HIV-1 Activity Targets the Fusion Peptide of HIV-1. Galatola, R., A. Vasconcelos, Y. Perez, A. Cruz, M. Pujol, M.A. Alsina, M.J. Gomara, and I. Haro. European Journal of Medicinal Chemistry, 2014. 86: p. 589-604. PMID[25218908].
[PubMed]. HIV_1024-110614.
6. Synthesis and anti-HIV-1 Screening of Novel N'-(1-(Aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-C][1,2]thiazi N-4(1H)-yl)acetohydrazides. Aslam, S., M. Ahmad, M. Zia-Ur-Rehman, C. Montero, M. Detorio, M. Parvez, and R.F. Schinazi. Archives of Pharmacal Research, 2014. 37(11): p. 1380-1393. PMID[23835833].
[PubMed]. HIV_1024-110614.
7. 1E7-03, a Low MW Compound Targeting Host Protein Phosphatase-1, Inhibits HIV-1 Transcription. Ammosova, T., M. Platonov, A. Ivanov, Y.S. Kont, N. Kumari, K. Kehn-Hall, M. Jerebtsova, A.A. Kulkarni, A. Uren, D. Kovalskyy, and S. Nekhai. British Journal of Pharmacology, 2014. 171(22): p. 5059-5075. PMID[25073485].
[PubMed]. HIV_1024-110614.
8. Investigating the Role of Metal Chelation in HIV-1 Integrase Strand Transfer Inhibitors. Bacchi, A., M. Carcelli, C. Compari, E. Fisicaro, N. Pala, G. Rispoli, D. Rogolino, T.W. Sanchez, M. Sechi, V. Sinisi, and N. Neamati. Journal of Medicinal Chemistry, 2011. 54(24): p. 8407-8420. PMID[22066494].
[PubMed]. HIV_1024-110614.
ISI Web of Knowledge Citations
9. Design, Synthesis and Biological Evaluation of Substituted Guanidine Indole Derivatives as Potential Inhibitors of HIV-1 Tat-Tar Interaction. Wang, J., Y. Wang, Z.Y. Li, P. Zhan, R.J. Bai, C. Pannecouque, J. Balzarini, C.E. De, and X.Y. Liu. Medicinal Chemistry, 2014. 10(7): p. 738-746. ISI[000342977300011].
[WOS]. HIV_1024-110614.
10. Synthesis and SARs of Indole-based Alpha-amino Acids as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Han, X., H.M. Wu, W. Wang, C.N. Dong, P. Tien, S.W. Wu, and H.B. Zhou. Organic & Biomolecular Chemistry, 2014. 12(41): p. 8308-8317. ISI[000342760800021].
[WOS]. HIV_1024-110614.